Stoneridge Investment Partners LLC Viatris Inc Transaction History

Stoneridge Investment Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$8.77 - $10.85 $2,473 - $3,059	-282 Reduced 0.49%	56,758 $615,000
Q3 2023 Nov 03, 2023	SELL	$9.59 - $11.35 $11,316 - $13,393	-1,180 Reduced 2.03%	57,040 $562,000
Q2 2023 Aug 04, 2023	BUY	$9.02 - $10.29 $113,038 - $128,954	12,532 Added 27.43%	58,220 $581,000
Q1 2023 Apr 28, 2023	SELL	$9.2 - $12.26 $193,080 - $257,300	-20,987 Reduced 31.48%	45,688 $440,000
Q1 2022 Apr 26, 2022	BUY	$9.81 - $15.4 $149,847 - $235,235	15,275 Added 29.72%	66,675 $725,000
Q4 2020 Feb 02, 2021	BUY	$14.3 - $18.74 $735,020 - $963,235	51,400 New	51,400 $963,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Stoneridge Investment Partners LLC with notifications on news.